A case report of SMARCA4-deficient undifferentiated tumor in the esophago-gastric junction

A case report of SMARCA4-deficient undifferentiated tumor in the esophago-gastric junction

Bibliographic Details
Main Authors:	Lili Deng, Baozhong Li
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Asian Journal of Surgery
Subjects:	SMARCA4-Deficient Esophagogastric junction adenocarcinoma Neoadjuvant Immunotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958423010850

Similar Items

Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report
by: Kei Kunimasa, MD, PhD, et al.
Published: (2021-11-01)

Primary SMARCA4-deficient undifferentiated sarcomatoid tumor of the gastroesophageal junction
by: Jiahan Liu, et al.
Published: (2020-11-01)

An aggressive case of a thoracic undifferentiated SMARCA4‐deficient tumor with extensive pleural involvement
by: Paul F. Hanona, et al.
Published: (2024-04-01)

Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go
by: Vito Longo, et al.
Published: (2024-03-01)

Thoracic SMARCA4-deficient undifferentiated tumor
by: Jiapeng Jiang, et al.
Published: (2023-04-01)

Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma
by: Jie Gao, et al.
Published: (2023-05-01)

Post-neoadjuvant chemoradiotherapy tumor resectability following induction chemotherapy in locally advanced proximal gastric and adenocarcinoma of the esophagogastric junction: A clinical trial
by: Seyed Amir Aledavood, et al.
Published: (2021-04-01)

Thoracic SMARCA4-deficient undifferentiated tumour: a case report
by: ZHANG Lanlan, YANG Qiao, NIE Zunzhen, GUO Ying
Published: (2023-08-01)

SMARCA4-deficient tumors in the adrenal gland and small intestines: A rare case report
by: Akira Kambe, MD, et al.
Published: (2024-02-01)

Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report
by: Yusuke Kito, et al.
Published: (2022-02-01)

Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor
by: Ping Zhou, et al.
Published: (2024-02-01)

A case of thoracic SMARCA4‐Deficient undifferentiated tumor successfully treated with combination Ipilimumab–Nivolumab
by: Yoshio Nakano, et al.
Published: (2022-12-01)

Clinicopathological characteristics and treatment outcomes of advanced SMARCA4‐deficient thoracic tumors
by: Anni Wang, et al.
Published: (2024-01-01)

Thoracic SMARCA4‐deficient undifferentiated tumour: Diagnostic challenges and potential for misdiagnosis in small tissue samples
by: Deborah Johanna Maartens, et al.
Published: (2023-11-01)

Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient with SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study
by: Nina Anžič, et al.
Published: (2021-05-01)

Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure
by: Liyong Shi, et al.
Published: (2022-11-01)

Prognostic impact of sarcopenia in patients with locally advanced adenocarcinoma of the esophagogastric junction treated with neoadjuvant chemoradiotherapy
by: Jiao Ming, et al.
Published: (2023-01-01)

Role of shrinkage in esophageal–gastric junction cancer
by: Maddalena Leongito, et al.
Published: (2023-06-01)

Diagnosis of a SMARCA4‐deficient undifferentiated tumor using multigene panel testing: A case report
by: Yoshiaki Marumo, et al.
Published: (2023-09-01)

The incidence of free peritoneal tumor cells before and after neoadjuvant chemotherapy in gastroesophageal junction cancer
by: Rune B Strandby, et al.
Published: (2020-01-01)

Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
by: Jinming Shi, et al.
Published: (2022-07-01)

Synchronous Malignant Gastrointestinal Neuroectodermal Tumor and SMARCA4-Deficient Undifferentiated Carcinoma With Independent Origins in the Small Intestine: A Case Report
by: Cuimin Chen, et al.
Published: (2021-08-01)

SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel
by: Kohei Yamashita, et al.
Published: (2024-03-01)

SIRGs score may be a predictor of prognosis and immunotherapy response for esophagogastric junction adenocarcinoma
by: Li-Ying OuYang, et al.
Published: (2022-08-01)

The Prognostic Impact of Histology in Esophageal and Esophago-Gastric Junction Adenocarcinoma
by: Roberto Fiocca, et al.
Published: (2021-10-01)

Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery
by: Zhenjiang Guo, et al.
Published: (2022-06-01)

Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
by: Halide Nur URER, et al.
Published: (2023-05-01)

Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review
by: Huanli Duan, et al.
Published: (2021-04-01)

Thoracic SMARCA4-Deficient Undifferentiated Tumor With ALK Fusion Treated With Alectinib Achieved Remarkable Tumor Regression: Case Report
by: Jin Sheng, MD, et al.
Published: (2023-04-01)

Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis
by: Xiangpeng Meng, et al.
Published: (2023-06-01)

Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial
by: Hyun Cheol Chung, et al.
Published: (2019-02-01)

Bioinformatic analysis of adenocarcinoma at esophagogastric junction and mutation sites screening of Involucrin gene
by: LYU Xue, LI Xue-wei, YANG Ting, ZHENG Jin-xiu, ZHU Zi-he, YANG Tao, XU Jun
Published: (2022-02-01)

Expression of Programmed Cell Death 1 and Lymphocyte Activation Gene 3 in Perioperation of Adenocarcinoma of Esophagogastric Junction and Related Significance
by: ZHANG Wei, et al.
Published: (2019-05-01)

The correlation between the margin of resection and prognosis in esophagogastric junction adenocarcinoma
by: Tao Pang, et al.
Published: (2023-10-01)

Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis
by: Jing Li, et al.
Published: (2021-03-01)

Case report: Gastric carcinoma with SMARCA4 deficient: two cases report and literature review
by: Zeyang Lin, et al.
Published: (2024-02-01)

Enhanced CT-based radiomics predicts pathological complete response after neoadjuvant chemotherapy for advanced adenocarcinoma of the esophagogastric junction: a two-center study
by: Wenpeng Huang, et al.
Published: (2022-08-01)

Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas
by: Gerd Jomrich, et al.
Published: (2019-09-01)

SMARCA4‐deficient lung tumour that presented with haemoptysis and progressed rapidly
by: Mari Inoue, et al.
Published: (2020-10-01)

Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma
by: Zhenkun Zhang, et al.
Published: (2022-12-01)